pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·2h ago·1 min read
save

HHS seeks public input on new vaccine recommendation categories under Trump and Kennedy

Aug 21, 2026·read at STAT ↗RegulatoryNeutral

A request for information was posted by the Department of Health and Human Services, giving the public a 30‑day window to comment on potential changes to the U.S. vaccine recommendation framework.

The RFI asks whether new categories should be added beyond the current three tiers – universal recommendations, risk‑based recommendations, and shared clinical decision‑making.

The move is being driven by President Donald Trump and Health Secretary Robert F. Kennedy Jr., who have signaled a desire to overhaul how childhood vaccines are administered.

While the document does not implement any policy changes, it signals that the administration is actively seeking input as part of a broader effort to reshape vaccine policy.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: HHS document offers new clues to Kennedy’s vaccine plans”

read at STAT ↗
469 words · retrieved 2h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Moderna, Inc.
topics
Vaccine8Vaccines3Infectious DiseaseMelanomaOncologyOphthalmologymRNA Therapeutic

related stories

  • 2d agoKolon TissueGene cuts 37 US staffers after Phase 3 failBioSpace
  • 2d agoMerck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval pushFierce Biotech
  • Aug 5The main therapy used for children with autism faces changes under MedicaidSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • May 13Opinion: The hantavirus is a wake-up call. Will the Trump administration answer it?STAT